Publications

Amit M, Liu C, Gleber-Netto FO, Kini S, Tam S, Benov A, Aashiq M, El-Naggar AK, Moreno AC, Rosenthal DI, Glisson BS, Ferrarotto R, Wong MK, Migden MR, Baruch EN, Li G, Khanna A, Goepfert RP, Nagarajan P, Weber RS, Myers JN, Gross ND. Inclusion of extranodal extension in the lymph node classification of cutaneous squamous cell carcinoma of the head and neck. Cancer. 2021 Apr 15;127(8):1238-1245. doi: 10.1002/cncr.33373. Epub 2020 Dec 15. PubMed PMID: 33320343.

Rasing MJA, Peters M, Moreno AC, Hofman EFN, Herder GJM, Welvaart PWN, Schramel FMNH, Lodeweges JE, Lin SH, Verhoeff JJC, van Rossum PSN. Predicting Incomplete Resection in Non-Small Cell Lung Cancer Preoperatively: A Validated Nomogram. Ann Thorac Surg. 2021 Mar;111(3):1052-1058. doi: 10.1016/j.athoracsur.2020.05.165. Epub 2020 Jul 31. PubMed PMID: 32739254.

Amit M, Liu C, Netto Gleber FO, Kini S, Tam S, Benov A, Aashiq M, El-Naggar AK, Moreno AC, Rosenthal DI, Glisson BS, Ferrarotto R, Wong MK, Migden MR, Li G, Khanna A, Goepfert RP, Nagarajan P, Weber RS, Myers JN, Gross ND. Integrating depth of invasion in T classification improves the prognostic performance of the American Joint Committee on Cancer primary tumor staging system for cutaneous squamous cell carcinoma of the head and neck. Eur J Cancer. 2021 Feb;144:169-177. doi: 10.1016/j.ejca.2020.11.019. Epub 2020 Dec 22. PubMed PMID: 33352413.

Christopherson KM, Moreno AC, Elgohari B, Gross N, Ferrarotto R, Mohamed ASR, Brandon Gunn G, Goepfert RP, Mott FE, Shah SJ, David Fuller C, Reddy JP, Frank SJ, Morrison WH, Phan J, Rosenthal DI, Garden AS. Outcomes after salvage for HPV-positive recurrent oropharyngeal cancer treated with primary radiation. Oral Oncol. 2021 Feb;113:105125. doi: 10.1016/j.oraloncology.2020.105125. Epub 2020 Dec

Wilke C, Takiar V, Wang H, Moreno AC, Tung SS, Quinlan-Davidson SR, Garden AS, Rosenthal DI, Fuller CD, Gunn GB, Reddy JP, Morrison WH, Wang C, Zhao G, Hutcheson KA, Phan J. Defining the dose-volume criteria for laryngeal sparing in locally advanced oropharyngeal cancer utilizing split-field IMRT, whole-field IMRT and VMAT. J Appl Clin Med Phys. 2021 Jan;22(1):37-44. doi: 10.1002/acm2.13009. Epub 2020 Dec 5. PubMed PMID: 33277960; PubMed Central PMCID: PMC7856483.

Zhu LL, Martin RM, Gunther JR, Wong PF, Hancock D, Moreno AC, Dabaja BS, Pinnix CC. Daily computed tomography image guidance: Dosimetric advantages outweigh low-dose radiation exposure for treatment of mediastinal lymphoma. Radiother Oncol. 2020 Nov;152:14-18. doi: 10.1016/j.radonc.2020.06.028. Epub 2020 Jun 25. PubMed PMID: 32593645.

Bagley AF, Garden AS, Reddy JP, Moreno AC, Frank SJ, Rosenthal DI, Morrison WH, Gunn GB, Fuller CD, Shah SJ, Ferrarotto R, Sturgis EM, Gross ND, Phan J. Highly conformal reirradiation in patients with prior oropharyngeal radiation: Clinical efficacy and toxicity outcomes. Head Neck. 2020 Nov;42(11):3326-3335. doi: 10.1002/hed.26384. Epub 2020 Aug 9. PubMed PMID: 32776401; PubMed Central PMCID: PMC7722120.

Grant SR, Williamson TD, Stieb S, Shah SJ, David Fuller C, Rosenthal DI, Frank SJ, Garden AS, Morrison WH, Phan J, Moreno AC, Reddy JP, Cardoso RC, Liu AY, Wu RY, Gunn GB. A Dosimetric Comparison of Oral Cavity Sparing in the Unilateral Treatment of Early Stage Tonsil Cancer: IMRT, IMPT, and Tongue-Deviating Oral Stents. Adv Radiat Oncol. 2020 Nov-Dec;5(6):1359-1363. doi: 10.1016/j.adro.2020.08.007. eCollection 2020 Nov-Dec. PubMed PMID: 33305099; PubMed Central PMCID: PMC7718552.

Moreno AC, Gunther JR, Milgrom S, Fuller CD, Williamson T, Liu A, Wu R, Zhu XR, Dabaja BS, Pinnix CC. Effect of Deep Inspiration Breath Hold on Normal Tissue Sparing With Intensity Modulated Radiation Therapy Versus Proton Therapy for Mediastinal Lymphoma. Adv Radiat Oncol. 2020 Nov-Dec;5(6):1255-1266. doi: 10.1016/j.adro.2020.08.004. eCollection 2020 Nov-Dec. PubMed PMID: 33305086; PubMed Central PMCID: PMC7718527.

Moreno AC, Lin SH. Authors' Reply to Yajing Du's Letter to the Editor on "Biologically Effective Dose in Stereotactic Body Radiotherapy and Survival for Patients With Early-Stage NSCLC". J Thorac Oncol. 2020 Oct;15(10):e166-e168. doi: 10.1016/j.jtho.2020.07.002. PubMed PMID: 32981605.

Mesko S, Wang H, Tung S, Wang C, Pasalic D, Ning MS, Pezzi TA, Moreno AC, Reddy JP, Garden AS, Rosenthal DI, Gunn GB, Frank SJ, Fuller CD, Morrison W, Su SY, Hanna E, Phan J. SABR for Skull Base Malignancies: A Systematic Analysis of Set-Up and Positioning Accuracy. Pract Radiat Oncol. 2020 Sep - Oct;10(5):363-371. doi: 10.1016/j.prro.2020.02.016. Epub 2020 Mar 30. PubMed PMID: 32240823.

Grant SR, Hutcheson KA, Ye R, Garden AS, Morrison WH, Rosenthal DI, Brandon Gunn G, Fuller CD, Phan J, Reddy JP, Moreno AC, Lewin JS, Sturgis EM, Ferrarotto R, Frank SJ. Prospective longitudinal patient-reported outcomes of swallowing following intensity modulated proton therapy for oropharyngeal cancer. Radiother Oncol. 2020 Jul;148:133-139. doi: 10.1016/j.radonc.2020.04.021. Epub 2020 Apr 21. PubMed PMID: 32361662; NIHMSID:NIHMS1586578.

Ng SP, Cardenas CE, Elhalawani H, Pollard C 3rd, Elgohari B, Fang P, Meheissen M, Guha-Thakurta N, Bahig H, Johnson JM, Kamal M, Garden AS, Reddy JP, Su SY, Ferrarotto R, Frank SJ, Brandon Gunn G, Moreno AC, Rosenthal DI, Fuller CD, Phan J. Comparison of tumor delineation using dual energy computed tomography versus magnetic resonance imaging in head and neck cancer re-irradiation cases. Phys Imaging Radiat Oncol. 2020 Apr;14:1-5. doi: 10.1016/j.phro.2020.04.001. eCollection 2020 Apr. PubMed PMID: 33458306; PubMed Central PMCID: PMC7807720.

Jiang W, Verma V, Haque W, Moreno AC, Koshy M, Butler EB, Teh BS. Post-treatment mortality after definitive chemoradiotherapy versus resection for esophageal cancer. Dis Esophagus. 2020 Apr 15;33(4). doi: 10.1093/dote/doz073. PubMed PMID: 31504359.

Moreno AC, Fellman B, Hobbs BP, Liao Z, Gomez DR, Chen A, Hahn SM, Chang JY, Lin SH. Biologically Effective Dose in Stereotactic Body Radiotherapy and Survival for Patients With Early-Stage NSCLC. J Thorac Oncol. 2020 Jan;15(1):101-109. doi: 10.1016/j.jtho.2019.08.2505. Epub 2019 Aug 31. PubMed PMID: 31479748.

Moreno AC, Lin YH, Bedrosian I, Shen Y, Babiera GV, Shaitelman SF. Outcomes after Treatment of Metaplastic Versus Other Breast Cancer Subtypes. J Cancer. 2020;11(6):1341-1350. doi: 10.7150/jca.40817. eCollection 2020. PubMed PMID: 32047541; PubMed Central PMCID: PMC6995376.

Mesko S, Wang H, Tung S, Wang C, Pasalic D, Chapman BV, Moreno AC, Reddy JP, Garden AS, Rosenthal DI, Gunn GB, Frank SJ, Fuller CD, Morrison W, Phan J. Estimating PTV Margins in Head and Neck Stereotactic Ablative Radiation Therapy (SABR) Through Target Site Analysis of Positioning and Intrafractional Accuracy. Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):185-193. doi: 10.1016/j.ijrobp.2019.09.010. Epub 2019 Sep 30. PubMed PMID: 31580928; PubMed Central PMCID: PMC7307590.

Moreno AC, Wilke C, Wang H, Tung S, Pollard III C, Garden AS, Morrison WH, Rosenthal DI, Fuller CD, Gunn GB, Reddy JP, Shah SJ, Frank SJ, Takiar V, Phan J. Optimizing laryngeal sparing with intensity modulated radiotherapy or volumetric modulated arc therapy for unilateral tonsil cancer. Physics and imaging in radiation oncology. 2019 April; 10:29-34. doi: https://doi.org/10.1016/j.phro.2019.04.002.

Cushman TR, Shaaban SG, Moreno AC, Lin C, Verma V. Management of Unresectable T4b Esophageal Cancer: Practice Patterns and Outcomes From the National Cancer Data Base. Am J Clin Oncol. 2019 Feb;42(2):154-159. doi: 10.1097/COC.0000000000000499. PubMed PMID: 30499838.

Moreno AC, Zhang N, Verma V, Giordano SH, Lin SH. Treatment disparities affect outcomes for patients with stage I esophageal cancer: a national cancer data base analysis. J Gastrointest Oncol. 2019 Feb;10(1):74-84. doi: 10.21037/jgo.2018.10.04. PubMed PMID: 30788162; PubMed Central PMCID: PMC6351305.

Moreno AC, Lin SH. The optimal treatment approaches for stage I small cell lung cancer. Transl Lung Cancer Res. 2019 Feb;8(1):88-96. doi: 10.21037/tlcr.2018.11.03. Review. PubMed PMID: 30788238; PubMed Central PMCID: PMC6351402.

Moreno AC, Frank SJ, Garden AS, Rosenthal DI, Fuller CD, Gunn GB, Reddy JP, Morrison WH, Williamson TD, Holliday EB, Phan J, Blanchard P. Intensity modulated proton therapy (IMPT) - The future of IMRT for head and neck cancer. Oral Oncol. 2019 Jan;88:66-74. doi: 10.1016/j.oraloncology.2018.11.015. Epub 2018 Nov 21. Review. PubMed PMID: 30616799; PubMed Central PMCID: PMC6615027.

Moreno AC, Zhang N, Giordano SH, Liao Z, Gomez D, Chang JY, Lin SH. Trends and Outcomes of Proton Radiation Therapy Use for Non-Small Cell Lung Cancer. Int J Part Ther. 2018 Fall;5(2):18-27. doi: 10.14338/IJPT/18-00029.1. Epub 2018 Nov 30. PubMed PMID: 31773031; PubMed Central PMCID: PMC6874194.

Fang P, Musall BC, Son JB, Moreno AC, Hobbs BP, Carter BW, Fellman BM, Mawlawi O, Ma J, Lin SH. Multimodal Imaging of Pathologic Response to Chemoradiation in Esophageal Cancer. Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):996-1001. doi: 10.1016/j.ijrobp.2018.02.029. Epub 2018 Mar 2. PubMed PMID: 29685377; PubMed Central PMCID: PMC6119639.

Matuszak MM, Fuller CD, Yock TI, Hess CB, McNutt T, Jolly S, Gabriel P, Mayo CS, Thor M, Caissie A, Rao A, Owen D, Smith W, Palta J, Kapoor R, Hayman J, Waddle M, Rosenstein B, Miller R, Choi S, Moreno A, Herman J, Feng M. Performance/outcomes data and physician process challenges for practical big data efforts in radiation oncology. Med Phys. 2018 Oct;45(10):e811-e819. doi: 10.1002/mp.13136. Epub 2018 Sep 19. PubMed PMID: 30229946; PubMed Central PMCID: PMC6679351.

Moreno AC, Haque W, Verma V, Fang P, Lin SH. Concurrent Versus Sequential Chemoradiation Therapy in Completely Resected Pathologic N2 Non-Small Cell Lung Cancer: Propensity-Matched Analysis of the National Cancer Data Base. Ann Surg Oncol. 2018 May;25(5):1245-1253. doi: 10.1245/s10434-018-6399-4. Epub 2018 Feb 26. PubMed PMID: 29484562.

Verma V, Moreno AC, Haque W, Fang P, Lin SH. Sequential Versus Concurrent Chemoradiation Therapy by Surgical Margin Status in Resected Non-Small Cell Lung Cancer. J Natl Compr Canc Netw. 2018 May;16(5):508-516. doi: 10.6004/jnccn.2018.7007. PubMed PMID: 29752325.

Verma V, Surkar SM, Moreno AC, Lin C, Simone CB 2nd. Practice patterns and outcomes of chemoradiotherapy versus radiotherapy alone for older patients with nasopharyngeal cancer. Cancer Med. 2018 May;7(5):1604-1611. doi: 10.1002/cam4.1290. Epub 2018 Mar 30. PubMed PMID: 29603669; PubMed Central PMCID: PMC5943491.

Corso CD, Park HS, Moreno AC, Kim AW, Yu JB, Husain ZA, Decker RH. Stage I Lung SBRT Clinical Practice Patterns. Am J Clin Oncol. 2017 Aug;40(4):358-361. doi: 10.1097/COC.0000000000000162. PubMed PMID: 25503436.

Moreno AC, Shaitelman SF, Buchholz TA. A clinical perspective on regional nodal irradiation for breast cancer. Breast. 2017 Aug;34 Suppl 1:S85-S90. doi: 10.1016/j.breast.2017.06.035. Epub 2017 Jul 8. Review. PubMed PMID: 28690104.

Xu C, Xi M, Moreno A, Shiraishi Y, Hobbs BP, Huang M, Komaki R, Lin SH. Definitive Chemoradiation Therapy for Esophageal Cancer in the Elderly: Clinical Outcomes for Patients Exceeding 80 Years Old. Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):811-819. doi: 10.1016/j.ijrobp.2017.02.097. Epub 2017 Mar 1. PubMed PMID: 28602412.

Moreno AC, Lin YH, Bedrosian I, Shen Y, Stauder MC, Smith BD, Buchholz TA, Babiera GV, Woodward WA, Shaitelman SF. Use of regional nodal irradiation and its association with survival for women with high-risk, early stage breast cancer: A National Cancer Database analysis. Adv Radiat Oncol. 2017 Jul-Sep;2(3):291-300. doi: 10.1016/j.adro.2017.04.008. eCollection 2017 Jul-Sep. PubMed PMID: 29114595; PubMed Central PMCID: PMC5605314.

Moreno AC, Verma V, Hofstetter WL, Lin SH. Patterns of Care and Treatment Outcomes of Elderly Patients with Stage I Esophageal Cancer: Analysis of the National Cancer Data Base. J Thorac Oncol. 2017 Jul;12(7):1152-1160. doi: 10.1016/j.jtho.2017.04.004. Epub 2017 Apr 25. PubMed PMID: 28455149.

Verma V, Moreno AC, Lin SH. Advances in Radiotherapy Management of Esophageal Cancer. J Clin Med. 2016 Oct 21;5(10). doi: 10.3390/jcm5100091. Review. PubMed PMID: 27775643; PubMed Central PMCID: PMC5086593.

Liu J, Hancock JG, Moreno AC, Wang Z, Boffa DJ, Detterbeck FC, Kim AW. Evaluating the fate of patients who undergo resections of very large, node-negative lung cancers using the National Cancer DataBase. Eur J Cardiothorac Surg. 2016 Feb;49(2):596-601. doi: 10.1093/ejcts/ezv139. Epub 2015 Apr 18. PubMed PMID: 25890936.

Hancock JG, Rosen JE, Antonicelli A, Moreno A, Kim AW, Detterbeck FC, Boffa DJ. Impact of adjuvant treatment for microscopic residual disease after non-small cell lung cancer surgery. Ann Thorac Surg. 2015 Feb;99(2):406-13. doi: 10.1016/j.athoracsur.2014.09.033. Epub 2014 Dec 17. PubMed PMID: 25528723.

Boffa DJ, Hancock JG, Yao X, Goldberg S, Rosen JE, Kim AW, Moreno A, Detterbeck FC. Now or later: evaluating the importance of chemotherapy timing in resectable stage III (N2) lung cancer in the National Cancer Database. Ann Thorac Surg. 2015 Jan;99(1):200-8. doi: 10.1016/j.athoracsur.2014.08.040. Epub 2014 Nov 20. PubMed PMID: 25440272.

Hancock J, Rosen J, Moreno A, Kim AW, Detterbeck FC, Boffa DJ. Management of clinical stage IIIA primary lung cancers in the National Cancer Database. Ann Thorac Surg. 2014 Aug;98(2):424-32; discussion 432. doi: 10.1016/j.athoracsur.2014.04.067. Epub 2014 Jun 12. PubMed PMID: 24929895.

Moreno AC, Morgensztern D, Boffa DJ, Decker RH, Yu JB, Detterbeck FC, Wang Z, Rose MG, Kim AW. Treating locally advanced disease: an analysis of very large, hilar lymph node positive non-small cell lung cancer using the National Cancer Data Base. Ann Thorac Surg. 2014 Apr;97(4):1149-55. doi: 10.1016/j.athoracsur.2013.12.045. Epub 2014 Feb 26. PubMed PMID: 24582051.

Moreno AC, Morgensztern D, Yu JB, Boffa DJ, Decker RH, Detterbeck FC, Kim AW. Impact of preoperative radiation on survival of patients with T3N0 >7-cm non-small cell lung cancers treated with anatomic resection using the Surveillance, Epidemiology, and End Results database. J Surg Res. 2013 Sep;184(1):10-8. doi: 10.1016/j.jss.2013.03.053. Epub 2013 Apr 3. PubMed PMID: 23583079.

Moreno A, Akcakanat A, Munsell MF, Soni A, Yao JC, Meric-Bernstam F. Antitumor activity of rapamycin and octreotide as single agents or in combination in neuroendocrine tumors. Endocr Relat Cancer. 2008 Mar;15(1):257-66. doi: 10.1677/ERC-07-0202. PubMed PMID: 18310292.